Inflammation Clinical Trial
Official title:
Enhancement of Presence, Compassion and Resilience Bringing the Practice of Mindfulness Into Nature - Preventing Mental Fatigue in Healthcare Professionals.
The purpose of the study is to determine whether a five day mindfulness retreat in nature can
increase measures of attention and self-compassion, and reduce stress among bachelor students
at Danish Universities and University Colleges. Secondary whether the expression of
inflammatory markers can be reduced .
It is the hypothesis that perceived stress is reduced and the expression of genetic markers
of inflammation is reduced after a five day mindfulness retreat.
Status | Recruiting |
Enrollment | 72 |
Est. completion date | November 2018 |
Est. primary completion date | March 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Bachelor student at a Danish University or University College - A score of 16 or above on the Perceived Stress Scale (PSS) Exclusion Criteria: - Smoking - Psychiatric diagnosis (depression, anxiety, adjustment disorder, PTSD, personality disorder, psychosis). - Untreated ADHD, autism, abuse and risk of suicide |
Country | Name | City | State |
---|---|---|---|
Denmark | VIA University College | Aarhus | |
Denmark | Nacadia, University of Copenhagen | Hoersholm |
Lead Sponsor | Collaborator |
---|---|
VIA University College | University of Aarhus, University of Copenhagen |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Perceived Stress Scale | PSS | At the end of five days retreat | |
Primary | Self-compassion | S-C-S Neff2 | At the end of five days retreat | |
Secondary | Five Facet Mindfulness Questionnaire | At the end of five days retreat | ||
Secondary | Breath Counting | Behavioral measurement of attention | At the end of five days retreat | |
Secondary | NF-kB gene expression | At the end of five days retreat | ||
Secondary | IL-1 gene expression | At the end of five days retreat | ||
Secondary | IL-6 gene expression | At the end of five days retreat | ||
Secondary | cRP expression | c reactive protein | At the end of five days retreat | |
Secondary | Heart Rate Variability | HRV | At the end of five days retreat | |
Secondary | Blood pressure | At the end of five days retreat | ||
Secondary | Connectedness to Nature Scale | At the end of five days retreat | ||
Secondary | GR gene expression | At the end of five days retreat | ||
Secondary | RIPK2 gene expression | At the end of five days retreat | ||
Secondary | TNF-a gene expression | At the end of five days retreat | ||
Secondary | CCL5 gene expression | At the end of five days retreat | ||
Secondary | IL-8 gene expression | At the end of five days retreat | ||
Secondary | TERT gene expression | At the end of five days retreat | ||
Secondary | TERC gene expression | At the end of five days retreat | ||
Secondary | IL-1ß protein expression | At the end of five days retreat | ||
Secondary | IL-2 protein expression | At the end of five days retreat | ||
Secondary | IL-4 protein expression | At the end of five days retreat | ||
Secondary | IL-6 protein expression | At the end of five days retreat | ||
Secondary | IL-8 protein expression | At the end of five days retreat | ||
Secondary | IL-10 protein expression | At the end of five days retreat | ||
Secondary | IL-12p70 protein expression | At the end of five days retreat | ||
Secondary | IL-13 protein expression | At the end of five days retreat | ||
Secondary | TNF-a protein expression | At the end of five days retreat | ||
Secondary | IFN-? protein expression | At the end of five days retreat |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Completed |
NCT03318731 -
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
|
N/A | |
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT06422494 -
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II
|
N/A |